Organon Abandons Gepirone Following Second “Not Approvable” Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Company will withdraw NDA for the antidepressant, which it had planned to market as Variza. With Implanon, Organon has one potential 2004 launch remaining; other new products are not expected before 2006-2007